With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—again kdunleavy Thu, 08/12/2021 – 10:00 More: With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—again
read morePresident Biden backs Medicare negotiations and price-hike penalties. But will Congress go along? fkansteiner Thu, 08/12/2021 – 09:39 More: President Biden backs Medicare negotiations and price-hike penalties. But will Congress go along? Source: fierce
read moreThe 2021 Communications Awards will be closing its doors for entry on the 10th of September. More: Entry closing next month for the 2021 Communications Awards Source: News
read moreCombination treatment reduced the risk of disease progression or death by 61% versus Sutent More: FDA approves Keytruda plus Lenvima for advanced kidney cancer Source: News
read moreTrial will aim to generate additional safety and immunogenicity data More: Further clinical trial planned for Valneva’s COVID-19 vaccine candidate Source: News
read moreFDA has requested an additional clinical trial on the safety of roxadustat More: US rejects AZ and FibroGen’s anaemia drug roxadustat Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals